Introduction of biosimilar insulins in Europe
Sign Up to like & getrecommendations! Published in 2017 at "Diabetic Medicine"
DOI: 10.1111/dme.13400
Abstract: Regulatory approval of the first biosimilar insulin in Europe, LY2963016 insulin glargine (Abasaglar®), in 2014 expanded the treatment options available to people with diabetes. As biosimilar insulin products come to market, it is important to… read more here.
Keywords: insulin; insulins europe; insulin glargine; biosimilar insulin ... See more keywords